249 related articles for article (PubMed ID: 19497484)
1. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability.
Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC
Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis.
Kurt M; Akdogan M; Onal IK; Kekilli M; Arhan M; Shorbagi A; Aksu S; Kurt OK; Haznedaroglu IC
Dig Liver Dis; 2010 Mar; 42(3):196-9. PubMed ID: 19540818
[TBL] [Abstract][Full Text] [Related]
3. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract.
Kurt M; Kacar S; Onal IK; Akdogan M; Haznedaroglu IC
Endoscopy; 2008 Sep; 40 Suppl 2():E262. PubMed ID: 19090459
[No Abstract] [Full Text] [Related]
4. A new hemostatic agent--Ankaferd blood stopper: management of gastrointestinal bleeding in an infant and other experiences in children.
Yarali N; Oruc M; Bay A; Dalgic B; Bozkaya IO; Arıkoglu T; Kara A; Tunc B
Pediatr Hematol Oncol; 2010 Nov; 27(8):592-6. PubMed ID: 20863156
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
[TBL] [Abstract][Full Text] [Related]
6. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
[TBL] [Abstract][Full Text] [Related]
7. Successful topical application of Ankaferd blood stopper in a patient with life-threatening fundal variceal bleeding despite cyanoacrilate injection.
Beyazit Y; Akdogan M; Sayilir A; Torun S; Suvak B; Kurt M
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):e9-11. PubMed ID: 21868302
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
[TBL] [Abstract][Full Text] [Related]
9. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper.
Purnak T; Ozaslan E; Beyazit Y; Haznedaroglu IC
Phytother Res; 2011 Feb; 25(2):312-3. PubMed ID: 20677211
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper.
Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC
Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic topical application of Ankaferd Blood Stopper® in gastrointestinal bleeding.
Karaman A; Baskol M; Gursoy S; Torun E; Yurci A; Celikbilek M; Guven K; Ozbakir O; Yucesoy M
J Altern Complement Med; 2012 Jan; 18(1):65-8. PubMed ID: 22268970
[TBL] [Abstract][Full Text] [Related]
12. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation.
Zulfikar OB; Emiroglu HH; Kebudi R
Dig Liver Dis; 2011 Mar; 43(3):247-8. PubMed ID: 21177146
[No Abstract] [Full Text] [Related]
13. The effect of Ankaferd blood stopper on severe radiation colitis.
Ozaslan E; Purnak T; Yildiz A; Akar T; Avcioglu U; Haznedaroglu IC
Endoscopy; 2009; 41 Suppl 2():E321-2. PubMed ID: 19921611
[No Abstract] [Full Text] [Related]
14. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience.
Baykul T; Alanoglu EG; Kocer G
J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971
[TBL] [Abstract][Full Text] [Related]
15. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper.
Ergenoglu MU; Yerebakan H; Kucukaksu DS
Heart Surg Forum; 2010 Dec; 13(6):E379-80. PubMed ID: 21169147
[TBL] [Abstract][Full Text] [Related]
16. Ankaferd hemostat for the management of tumoral GI bleeding.
Beyazit Y; Kekilli M; Kurt M; Sayilir A; Haznedaroglu IC
Gastrointest Endosc; 2011 May; 73(5):1072-3. PubMed ID: 21521581
[No Abstract] [Full Text] [Related]
17. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model.
Iynen I; Sogut O; Kose R
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339
[TBL] [Abstract][Full Text] [Related]
19. Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses.
Ozel-Demiralp D; Igci N; Ayhan B; Egin Y; Haznedaroglu IC; Akar N
Clin Appl Thromb Hemost; 2012 Nov; 18(6):604-10. PubMed ID: 22327821
[TBL] [Abstract][Full Text] [Related]
20. Topical Ankaferd Blood Stopper administration to bleeding gastrointestinal carcinomas decreases tumor vascularization.
Turhan N; Kurt M; Shorbagi A; Akdogan M; Haznedaroglu IC
Am J Gastroenterol; 2009 Nov; 104(11):2874-7. PubMed ID: 19888263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
